» Articles » PMID: 12827055

Decreased Pigment Epithelium-derived Factor and Increased Vascular Endothelial Growth Factor Levels in Pterygia

Overview
Journal Cornea
Specialty Ophthalmology
Date 2003 Jun 27
PMID 12827055
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Pterygia are histologically composed of proliferating fibrovascular tissue. This study compared expression levels of an angiogenic inhibitor, pigment epithelium-derived factor (PEDF), in pterygia with those in normal corneal and conjunctival tissues.

Methods: The normal human conjunctival and corneal tissues were obtained from surgery or from donor eyes without ocular diseases. Pterygia were excised by therapeutic surgery under a microscope. Pigment epithelium-derived factor and vascular endothelial growth factor (VEGF) were measured by Western blot analysis. Their cellular localizations were determined by immunohistochemistry.

Results: Intensive PEDF immunostaining was detected in all the normal corneal and conjunctival samples analyzed, predominantly in the epithelium and endothelium of the cornea and in the epithelium of the limbus and conjunctiva. Under the same immunostaining conditions, pterygial samples showed negative or faint PEDF staining. In contrast, the same pterygial samples all showed intensive VEGF staining, predominantly in the epithelium and in blood vessels. Western blot analysis confirmed that the average PEDF level in pterygia was drastically lower than those in normal corneal and conjunctival tissues, respectively. In contrast, the VEGF level in pterygia was significantly higher than in the normal tissues.

Conclusion: Pterygia exhibit significantly lower PEDF but higher VEGF levels than those in normal corneas and conjunctivae. The decreased PEDF level in pterygia may play a role in the formation and progression of pterygia.

Citing Articles

The efficacy and safety of continuous blanket suture for severe recurrent pterygium with symblepharon.

Ma H, Shen J, Chen X, Ye X, Xu S, Zhang Z Ther Adv Ophthalmol. 2024; 16:25158414241294191.

PMID: 39534272 PMC: 11555734. DOI: 10.1177/25158414241294191.


Efficacy of epidermal growth factor in suppressing inflammation and proliferation in pterygial fibroblasts through interactions with microenvironmental M1 macrophages.

Lee S, Koh A, Lee S, Kim K Sci Rep. 2024; 14(1):22601.

PMID: 39349715 PMC: 11442942. DOI: 10.1038/s41598-024-74413-5.


Unravelling the molecular tapestry of pterygium: insights into genes for diagnostic and therapeutic innovations.

Gupta M, Arya S, Agrawal P, Gupta H, Sikka R Eye (Lond). 2024; 38(15):2880-2887.

PMID: 38907016 PMC: 11461965. DOI: 10.1038/s41433-024-03186-y.


Elucidating the mechanism of corneal epithelial cell repair: unraveling the impact of growth factors.

Gong J, Ding G, Hao Z, Li Y, Deng A, Zhang C Front Med (Lausanne). 2024; 11:1384500.

PMID: 38638937 PMC: 11024251. DOI: 10.3389/fmed.2024.1384500.


Expression of placental growth factor, neuropilin-1, and neuropilin-2 in primary pterygium tissue.

Gundogan A, Oltulu R, Belviranli S, Oltulu P Graefes Arch Clin Exp Ophthalmol. 2023; 262(3):957-965.

PMID: 37878035 DOI: 10.1007/s00417-023-06280-1.